 |
Turna Ray is the editor of GenomeWeb's Pharmacogenomics Reporter. She covers pharmacogenomics, personalized medicine, and companion diagnostics. E-mail Turna Ray or follow her GenomeWeb Twitter account at @PGxReporter. |
Palmetto's Loss of Jurisdiction E Medicare Contract Raises Questions About Fate of MolDx Program
October 17, 2012
Palmetto's Loss of Jurisdiction E Medicare Contract Raises Questions About Fate of MolDx Program
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Palmetto Issuing 'Z-Codes' to Track Molecular Dx Utilization, Gather Data CPT Codes Can't Provide
November 16, 2011 / Pharmacogenomics Reporter - AMA Threatens to File HIPAA Complaint Unless CMS Halts Program Requiring Z-Codes for MDx Tests
January 4, 2012 / Pharmacogenomics Reporter - Palmetto Loses Appeal to Remain JE CMS Contractor, but May Continue Running MolDx
January 30, 2013 / Pharmacogenomics Reporter - CMS Stance on Reimbursement of Multi-Analyte Algorithm Assays Raises Industry Concerns
September 19, 2012 / Pharmacogenomics Reporter - European Researchers and Pharmas Launch Effort to Link Gene Markers to Diabetes, Personalize Drugs
February 29, 2012 / Pharmacogenomics Reporter